BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

833 related articles for article (PubMed ID: 25907958)

  • 21. Silencing UHRF1 Inhibits Cell Proliferation and Promotes Cell Apoptosis in Retinoblastoma Via the PI3K/Akt Signalling Pathway.
    Liu Y; Liang G; Zhou T; Liu Z
    Pathol Oncol Res; 2020 Apr; 26(2):1079-1088. PubMed ID: 31044388
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Inhibition of FOXO1/3 promotes vascular calcification.
    Deng L; Huang L; Sun Y; Heath JM; Wu H; Chen Y
    Arterioscler Thromb Vasc Biol; 2015 Jan; 35(1):175-83. PubMed ID: 25378413
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A novel tumor suppressor network in squamous malignancies.
    Costa C; Santos M; Segrelles C; Dueñas M; Lara MF; Agirre X; Prosper F; García-Escudero R; Paramio JM
    Sci Rep; 2012; 2():828. PubMed ID: 23145321
    [TBL] [Abstract][Full Text] [Related]  

  • 24. PTEN-mediated Akt/β-catenin/Foxo1 signaling regulates innate immune responses in mouse liver ischemia/reperfusion injury.
    Kamo N; Ke B; Busuttil RW; Kupiec-Weglinski JW
    Hepatology; 2013 Jan; 57(1):289-98. PubMed ID: 22807038
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Inactivation of the Akt survival pathway during photoreceptor apoptosis in the retinal degeneration mouse.
    Jomary C; Cullen J; Jones SE
    Invest Ophthalmol Vis Sci; 2006 Apr; 47(4):1620-9. PubMed ID: 16565401
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Distinct patterns of expression of the RB gene family in mouse and human retina.
    Spencer C; Pajovic S; Devlin H; Dinh QD; Corson TW; Gallie BL
    Gene Expr Patterns; 2005 Jun; 5(5):687-94. PubMed ID: 15939381
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Overexpression of Biglycan is Associated with Resistance to Rapamycin in Human WERI-Rb-1 Retinoblastoma Cells by Inducing the Activation of the Phosphatidylinositol 3-Kinases (PI3K)/Akt/Nuclear Factor kappa B (NF-κB) Signaling Pathway.
    Fang D; Lai Z; Wang Y
    Med Sci Monit; 2019 Sep; 25():6639-6648. PubMed ID: 31483776
    [TBL] [Abstract][Full Text] [Related]  

  • 28. MiR-25-3p promotes malignant phenotypes of retinoblastoma by regulating PTEN/Akt pathway.
    Wan W; Wan W; Long Y; Li Q; Jin X; Wan G; Zhang F; Lv Y; Zheng G; Li Z; Zhu Y
    Biomed Pharmacother; 2019 Oct; 118():109111. PubMed ID: 31336343
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Medulloblastoma and retinoblastoma: oncology recapitulates ontogeny.
    Romer JT; Curran T
    Cell Cycle; 2004 Jul; 3(7):917-9. PubMed ID: 15254429
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The p107/E2F pathway regulates fibroblast growth factor 2 responsiveness in neural precursor cells.
    McClellan KA; Vanderluit JL; Julian LM; Andrusiak MG; Dugal-Tessier D; Park DS; Slack RS
    Mol Cell Biol; 2009 Sep; 29(17):4701-13. PubMed ID: 19564414
    [TBL] [Abstract][Full Text] [Related]  

  • 31. E2F-1 transcriptional activity is a critical determinant of Mdm2 antagonist-induced apoptosis in human tumor cell lines.
    Kitagawa M; Aonuma M; Lee SH; Fukutake S; McCormick F
    Oncogene; 2008 Sep; 27(40):5303-14. PubMed ID: 18521084
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The first knockout mouse model of retinoblastoma.
    Zhang J; Schweers B; Dyer MA
    Cell Cycle; 2004 Jul; 3(7):952-9. PubMed ID: 15190215
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Regulation of the retinoblastoma-E2F pathway by the ubiquitin-proteasome system.
    Sengupta S; Henry RW
    Biochim Biophys Acta; 2015 Oct; 1849(10):1289-97. PubMed ID: 26319102
    [TBL] [Abstract][Full Text] [Related]  

  • 34. E2F1/CKS2/PTEN signaling axis regulates malignant phenotypes in pediatric retinoblastoma.
    Chen M; Zhao Z; Wu L; Huang J; Yu P; Qian J; Ni T; Zhao C
    Cell Death Dis; 2022 Sep; 13(9):784. PubMed ID: 36096885
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Roles of the RAF/MEK/ERK and PI3K/PTEN/AKT pathways in malignant transformation and drug resistance.
    McCubrey JA; Steelman LS; Abrams SL; Lee JT; Chang F; Bertrand FE; Navolanic PM; Terrian DM; Franklin RA; D'Assoro AB; Salisbury JL; Mazzarino MC; Stivala F; Libra M
    Adv Enzyme Regul; 2006; 46():249-79. PubMed ID: 16854453
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The survival gene MED4 explains low penetrance retinoblastoma in patients with large RB1 deletion.
    Dehainault C; Garancher A; Castéra L; Cassoux N; Aerts I; Doz F; Desjardins L; Lumbroso L; Montes de Oca R; Almouzni G; Stoppa-Lyonnet D; Pouponnot C; Gauthier-Villars M; Houdayer C
    Hum Mol Genet; 2014 Oct; 23(19):5243-50. PubMed ID: 24858910
    [TBL] [Abstract][Full Text] [Related]  

  • 37. CHIP regulates AKT/FoxO/Bim signaling in MCF7 and MCF10A cells.
    Lv Y; Song S; Zhang K; Gao H; Ma R
    PLoS One; 2013; 8(12):e83312. PubMed ID: 24376685
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Rb1 and Pten Co-Deletion in Osteoblast Precursor Cells Causes Rapid Lipoma Formation in Mice.
    Filtz EA; Emery A; Lu H; Forster CL; Karasch C; Hallstrom TC
    PLoS One; 2015; 10(8):e0136729. PubMed ID: 26317218
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Retinoblastoma family proteins have distinct functions in pulmonary epithelial cells in vivo critical for suppressing cell growth and tumorigenesis.
    Simpson DS; Mason-Richie NA; Gettler CA; Wikenheiser-Brokamp KA
    Cancer Res; 2009 Nov; 69(22):8733-41. PubMed ID: 19887614
    [TBL] [Abstract][Full Text] [Related]  

  • 40. PI3K/AKT Pathway and Its Mediators in Thyroid Carcinomas.
    Nozhat Z; Hedayati M
    Mol Diagn Ther; 2016 Feb; 20(1):13-26. PubMed ID: 26597586
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 42.